Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland.
Anal Chem. 2013 Mar 5;85(5):2724-30. doi: 10.1021/ac303197p. Epub 2013 Feb 13.
Because of its favorable physicochemical properties, DMSO is the standard solvent for sample storage and handling of compounds in drug discovery. To date, little attention was given to how DMSO influences protein-ligand binding strengths. In this study we investigated the effects of DMSO on different noncovalent protein-ligand complexes, in particular in terms of the binding affinities, which we determined using nanoESI-MS. For the investigation, three different protein-ligand complexes were chosen: trypsin-Pefabloc, lysozyme-tri-N-acetylchitotriose (NAG3), and carbonic anhydrase-chlorothiazide. The DMSO content in the nanoESI buffer was increased systematically from 0.5 to 8%. For all three model systems, it was shown that the binding affinity decreases upon addition of DMSO. Even 0.5-1% DMSO alters the KD values, in particular for the tight binding system carbonic anhydrase-chlorothiazide. The determined dissociation constant (KD) is up to 10 times higher than for a DMSO-free sample in the case of carbonic anhydrase-chlorothiazide binding. For the trypsin-Pefabloc and lysozyme-NAG3 complexes, the dissociation constants are 7 and 3 times larger, respectively, in the presence of DMSO. This work emphasizes the importance of effects of DMSO as a co-solvent for quantification of protein-ligand binding strengths in the early stages of drug discovery.
由于其良好的物理化学性质,DMSO 是药物发现中化合物样品储存和处理的标准溶剂。迄今为止,人们很少关注 DMSO 如何影响蛋白质-配体结合强度。在这项研究中,我们研究了 DMSO 对不同非共价蛋白质-配体复合物的影响,特别是在结合亲和力方面,我们使用纳喷雾电喷雾质谱(nanoESI-MS)来确定。为此,选择了三种不同的蛋白质-配体复合物:胰蛋白酶-Pefabloc、溶菌酶-三-N-乙酰壳三糖(NAG3)和碳酸酐酶-氯噻嗪。在 nanoESI 缓冲液中,DMSO 的含量从 0.5%到 8%系统地增加。对于所有三种模型系统,均表明随着 DMSO 的加入,结合亲和力降低。即使添加 0.5-1%DMSO 也会改变 KD 值,特别是对于紧密结合的碳酸酐酶-氯噻嗪系统。在碳酸酐酶-氯噻嗪结合的情况下,确定的离解常数(KD)比无 DMSO 样品高 10 倍。对于胰蛋白酶-Pefabloc 和溶菌酶-NAG3 复合物,在存在 DMSO 的情况下,离解常数分别增大 7 倍和 3 倍。这项工作强调了 DMSO 作为共溶剂在药物发现早期定量蛋白质-配体结合强度的重要性。